Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Johnson

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|January 7, 2020
Mariana serpentinite mud volcanism exhumes subducted seamount materials: implications for the origin of lifePatricia Fryer, C Geoffrey Wheat, Trevor Williams, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 7, 2025
Cognitive impairment and p-tau217 are high in a vascular patient cohortScott R French, Juan C Arias, Summan Zahra, et al.
Journal of Medicinal Chemistry|June 8, 2013
Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trialsThomas H Marsilje, Wei Pei, Bei Chen, et al.
Journal of Medicinal Chemistry|March 22, 2021
Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron MicroscopyJack A Terrett, Huifen Chen, Daniel G Shore, et al.
Journal of the American Medical Informatics Association : JAMIA|April 29, 2022
A research agenda to support the development and implementation of genomics-based clinical informatics tools and resourcesKen Wiley, Laura Findley, Madison Goldrich, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|June 4, 2026
Corrigendum to "4D Flow cardiovascular magnetic resonance consensus statement: 2023 update" [Journal of Cardiovascular Magnetic Resonance 25 (2023) 40]Malenka M Bissell, Francesca Raimondi, Lamia Ait Ali, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|July 20, 2023
4D Flow cardiovascular magnetic resonance consensus statement: 2023 updateMalenka M Bissell, Francesca Raimondi, Lamia Ait Ali, et al.
Journal of Medicinal Chemistry|July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of LeishmaniasesAdvait Nagle, Agnes Biggart, Celine Be, et al.
JAMA|October 13, 2025
AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial IntelligenceDerek C Angus, Rohan Khera, Tracy Lieu, et al.
Journal of Medicinal Chemistry|March 3, 2024
Discovery of TRPA1 Antagonist <b>GDC-6599</b>: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory DiseaseJack A Terrett, Justin Q Ly, Paula Katavolos, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|January 7, 2020
Mariana serpentinite mud volcanism exhumes subducted seamount materials: implications for the origin of lifePatricia Fryer, C Geoffrey Wheat, Trevor Williams, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 7, 2025
Cognitive impairment and p-tau217 are high in a vascular patient cohortScott R French, Juan C Arias, Summan Zahra, et al.
Journal of Medicinal Chemistry|June 8, 2013
Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trialsThomas H Marsilje, Wei Pei, Bei Chen, et al.
Journal of Medicinal Chemistry|March 22, 2021
Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron MicroscopyJack A Terrett, Huifen Chen, Daniel G Shore, et al.
Journal of the American Medical Informatics Association : JAMIA|April 29, 2022
A research agenda to support the development and implementation of genomics-based clinical informatics tools and resourcesKen Wiley, Laura Findley, Madison Goldrich, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|June 4, 2026
Corrigendum to "4D Flow cardiovascular magnetic resonance consensus statement: 2023 update" [Journal of Cardiovascular Magnetic Resonance 25 (2023) 40]Malenka M Bissell, Francesca Raimondi, Lamia Ait Ali, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|July 20, 2023
4D Flow cardiovascular magnetic resonance consensus statement: 2023 updateMalenka M Bissell, Francesca Raimondi, Lamia Ait Ali, et al.
Journal of Medicinal Chemistry|July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of LeishmaniasesAdvait Nagle, Agnes Biggart, Celine Be, et al.
JAMA|October 13, 2025
AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial IntelligenceDerek C Angus, Rohan Khera, Tracy Lieu, et al.
Journal of Medicinal Chemistry|March 3, 2024
Discovery of TRPA1 Antagonist <b>GDC-6599</b>: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory DiseaseJack A Terrett, Justin Q Ly, Paula Katavolos, et al.
Pageof 17